Next Article in Journal
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine
Next Article in Special Issue
COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
Previous Article in Journal
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
Previous Article in Special Issue
The Influence of Time of Day of Vaccination with BNT162b2 on the Adverse Drug Reactions and Efficacy of Humoral Response against SARS-CoV-2 in an Observational Study of Young Adults
 
 
Article

Article Versions Notes

Vaccines 2022, 10(3), 446; https://doi.org/10.3390/vaccines10030446
Action Date Notes Link
article pdf uploaded. 14 March 2022 15:02 CET Version of Record https://www.mdpi.com/2076-393X/10/3/446/pdf-vor
article xml file uploaded 15 March 2022 10:48 CET Original file -
article xml uploaded. 15 March 2022 10:48 CET Update https://www.mdpi.com/2076-393X/10/3/446/xml
article pdf uploaded. 15 March 2022 10:48 CET Updated version of record https://www.mdpi.com/2076-393X/10/3/446/pdf
article html file updated 15 March 2022 10:49 CET Original file -
article html file updated 16 March 2022 10:01 CET Update https://www.mdpi.com/2076-393X/10/3/446/html
Back to TopTop